6 Jefferies Group Intra-Cellular Therapies Trades
Jefferies Group's position in Intra-Cellular Therapies is currently worth $3.94 Million. That's 0.08% of their equity portfolio (241st largest holding). The first Intra-Cellular Therapies trade was made in Q3 2023. Since then Jefferies Group bought shares three more times and sold shares on two occasions. The stake costed the investor $3.71 Million, netting the investor a gain of 6.3% so far.
News about Intra-Cellular Therapies Inc and Jefferies Group
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Holdings Reduced by Schroder Investment Management Group
… during the period. Schroder Investment Management Group’s holdings in … filing. Several other institutional investors and hedge funds have also … Targets W...
9,780 Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Acquired by Virtu Financial LLC
Virtu Financial LLC acquired a new position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) in the 2nd quarter, HoldingsChannel.com reports. The fund acquire...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Vanguard Group Inc.
Vanguard Group Inc. raised its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) by 1.6% during the 2nd quarter, Holdings Channel.com reports. The fir...
Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $48.00
Intra-Cellular Therapies (NASDAQ:ITCI) had its price objective boosted by Royal Bank of Canada from $44.00 to $48.00 in a research note published on Tuesday ...